Belpointe Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-374	Closed	-$8.62K	–	1271
2023 Q1	$8.62K	Hold	374	–	–	﹤0.01%	2794
2022 Q4	$10.4K	Buy	+374	New	+$10.4K	﹤0.01%	2597